# Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

> **NCT00255918** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 12 (actual)

## Conditions studied

- Schizophrenia
- Psychotic Disorders

## Interventions

- **DRUG:** Dimethoxybenzylidene anabaseine (DMXB-A)
- **DRUG:** Placebo
- **DRUG:** Dimethoxybenzylidene anabaseine (DMXB-A)

## Key facts

- **NCT ID:** NCT00255918
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255918, "Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00255918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*